NEW YORK – Drawing on its longstanding partnership with Becton Dickinson, Babson Diagnostics is aiming to further expand use of its US Food and Drug Administration-cleared blood collection system ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

The International Paralympic Committee (IPC) has sanctioned the Tokyo 2020 gold medallist following an adverse analytical ...

ApoB is emerging as a crucial piece of the heart health puzzle, even as sophisticated machines whir and beep with promises of ...

The phenomenon of a Full Moon arises when our planet, Earth, is precisely sandwiched between the Sun and the Moon. This alignment ensures the entire side of the Moon that faces us gleams under ...

Having debuted over the lucrative Christmas period, the music biopic A Complete Unknown was given a meticulously planned theatrical release. The film was allowed to run domestically before being ...

Here are the dates for the full moons in 2025. The next full moon will be on Friday, March 14, 2025. It will officially reach its full moon phase at 2:55 a.m. EDT (0755 GMT) but local moonrise ...

Metabolic engineering is the use of genetic engineering to modify the metabolism of an organism. It can involve the optimization of existing biochemical pathways or the introduction of pathway ...

Maxeon's newest residential panel is also its most efficient. It beats its nearest competitors by one full percentage point. It also has a temperature coefficient of -0.27%, which means it won't ...

If you want the best image quality from a mirrorless or DSLR camera, full-frame is the way to go. Based on our in-depth reviews, full-frame sensors continue to deliver superb results in any lighting.

Alabama Birmingham WBMA ABC 9:30 a.m., 11:30 p.m. (both Central time) Alabama Mobile / Pensacola WEAR ABC 9:00 a.m., 10:30 p.m. Alabama Mobile / Pensacola WPMI NBC 10:00 a.m. Alabama Mobile / ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...